Compare Heron Therapeutics Inc (HRTX) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Clear Secure Inc — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Clear Secure Inc trades at $43.36 (market cap $4.39B). The key difference: Clear Secure Inc is far larger — about 59.3× Heron Therapeutics Inc's market cap, and Clear Secure Inc pays a 1.35% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Clear Secure Inc for 19 Days on average.
| HRTX | YOU | |
|---|---|---|
Market Cap | $74.04M | $4.39B |
Volume | 3,668,095 | 1,899,845 |
Sector | Health | Technology |
52-Week High | $1.49 | $62.36 |
52-Week Low | $0.27 | $29.61 |
Typical Hold Time | 35 Days | 19 Days |
Enterprise Value | $180.78M | $3.54B |
Dividend Yield | — | 1.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Clear Secure (YOU) trades at $42.58, up 2.6% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with 27% revenue growth in Q2 2026, beating earnings estimates, and robust profitability margins. Recent partnership with CrowdStrike and corporate membership launch highlight growth initiatives. Analyst consensus is mixed with a $61.40 price target representing 44% upside potential.
The stock presents growth potential driven by expanding membership base and enterprise partnerships, but faces risks from competitive pressures and potential execution challenges. Current valuation at 28.77 P/E appears reasonable given growth trajectory, though technical indicators show some overbought conditions that may limit near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
